JAZZ FY 2017 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B+8.8% YoY

Gross Profit

$1.5B93.2% margin

Operating Income

$529M32.7% margin

Net Income

$488M30.1% margin

EPS (Diluted)

$7.96

Cash Flow

Operating Cash Flow

$693M

Free Cash Flow

$579M

Stock-Based Comp.

$107M

Balance Sheet

Total Assets

$5.1B

Total Liabilities

$2.4B

Stockholders' Equity

$2.7B

Cash & Equivalents

$386M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.5B	+8.8%
Gross Profit	$1.5B	$1.4B	+9.1%
Operating Income	$529M	$592M	-10.6%
Net Income	$488M	$397M	+22.9%